Robotic Versus Abdominal Surgery for Endometrial Cancer

NCT01847703CompletedNAINTERVENTIONAL

Summary

Key Facts

Lead Sponsor

Karolinska Institutet

Enrollment

120

Start Date

2013-04-01

Completion Date

2016-07-01

Study Type

INTERVENTIONAL

Official Title

Randomized Trial Comparing Robotic and Abdominal Surgery for High Risk Endometrial Cancer

Interventions

Robotic surgeryAbdominal surgery

Conditions

Endometrial Neoplasms

Eligibility

Age Range

18 Years – 75 Years

Sex

FEMALE

Inclusion Criteria:

* 18-75 years of age
* High risk endometrial cancer

Exclusion Criteria:

* WHO performance\>1
* Severe comorbidity, ASA\>3
* Unable to understand information

Outcome Measures

Primary Outcomes

Number of harvested lymph nodes

Extracted lymphatic tissue from 3 stations (above inferior mesenteric artery, below inferior mesenteric artery, pelvic) is analysed by a pathologist and the number of nodes for each station recorded and compared between the two groups

Time frame: 2 years

Secondary Outcomes

Recurrence of cancer

Cancer recurrences will be recorded up to 3 years after surgery and categorized according to anatomical site

Time frame: 3 years

Lymphatic side-effects

Lymphatic side-effects will be monitored by repeated computed tomography (CT) 3 months and 12 months after surgery. Enrolled women will be asked specific, validated questions at follow-up

Time frame: 2 years

Quality of life

All included participants will be asked to fill out a questionnaire (EORTC) to assess quality of life before and 1 year after surgery

Time frame: 2 years

Healthcare cost

All costs related to each procedure including complications, re-admissions, rehabilitation, medication, radiology will be compared after 1 year.

Time frame: 2 years

Locations

Karolinska University Hospital, Stockholm, Sweden